Kent Mark-Josef Adler's Trials
Trials not Recruiting
Study Title
Investigators
Disease Categories
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (excluding squamous cell)
(No longer recruiting)
Heather A. Wakelee
Kristen N. Ganjoo
Charlotte D Jacobs
Branimir I Sikic
Kent Mark-Josef Adler
Kristen N. Ganjoo
Charlotte D Jacobs
Branimir I Sikic
Kent Mark-Josef Adler
Lung Cancer
Help